Register for today's webinar on COVID-19 therapeutics transitioning to commercialization
The U.S. government is winding down control of the COVID-19 therapeutics distribution and moving towards commercialization, much like with vaccines earlier in the fall. The Administration for Strategic Preparedness and Response developed this resource outlining the transition plan. Merck and Pfizer are releasing additional information as well.